HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2184929Generated: October 31, 2026
4-(4-Chlorophenyl)-4-hydroxypiperidine → HCID 12043490, compound
https://huagongshe.com/reaction/2184929
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 4-(4-Chlorophenyl)-4-hydroxypiperidine | HCID 38282 | — |
| Reactant | tert-Butyl carbamate | HCID 77922 | — |
| Reactant | 1,4-Dioxane hydrochloride | HCID 20443148 | — |
| Reactant | HCID 70173098 | HCID 70173098 | — |
| Product | HCID 12043490 | HCID 12043490 | — |
Reaction Steps
3-[(9-Ethyl-9H-carbazol-3-ylcarbamoyl)-methyl]-3-aza-bicyclo[3.1.0]hex-6-yl}-carbamic acid tert-butyl ester was synthesized similarly to example 44, substituting 3-aza-bicyclo[3.1.0]hex-6-yl)-carbamic acid tert-butyl ester for 4-(4-Chlorophenyl)-4-hydroxypiperidine and substituting the compound of example 19 for the compound of example 40. A solution of {3-[(9-ethyl-9H-carbazol-3-ylcarbamoyl)-methyl]-3-aza-bicyclo[3.1.0]hex-6-yl}-carbamic acid tert-butyl ester (4.6 mmol) in 1:1 4 M HCl/dioxane (25 mL) was stirred at room temperature for 16 hours. The reaction mixture was then concentrated, and the residue was concentrated from diethyl ether (2×25 mL). The pale yellow foam remaining (723 mg, 37%) was N-(9-ethyl-9H-carbazol-3-yl)-2-(6-amino-3-aza-bicyclo[3.1.0]hex-3-yl)-acetamide.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06399631B1 |
|---|
| Source dataset | uspto-grants-2002_06 |
|---|
| ORD ID | ord-4991b74ae6df45f3b751b0cbb09a4dbf |
|---|
| Source note | uspto-grants-2002_06 |
|---|